Completed PHASE1 INTERVENTIONAL 2-arm NCT01731574

DDI Potential: Dapivirine Vaginal Ring and Miconazole Nitrate

An Open-label, Randomized, Three-period Crossover Trial in Healthy HIV-negative Women to Assess the Drug-drug Interaction Between Dapivirine Vaginal Ring-004 and Miconazole Nitrate

Sponsor: International Partnership for Microbicides, Inc.

Conditions HIV

Interventions dapivirine miconazole

Updated 7 times since 2017 Last updated: Sep 5, 2017 Started: Dec 31, 2012 Primary completion: Oct 31, 2013 Completion: Oct 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on HIV, this trial is completed. The trial is conducted by International Partnership for Microbicides, Inc. and has accumulated 7 data snapshots since 2012. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Oct 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Feb 2017 — Oct 2017 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

International Partnership for Microbicides, Inc.

Data source: International Partnership for Microbicides, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lange Beeldekensstraat 267, Belgium